Creating and testing computer methods to design therapeutic proteins.
The Development and Experimental Verification of Computational Methods to Design and Predict the Properties of Therapeutic Proteins
['FUNDING_OTHER'] · AUBURN UNIVERSITY AT AUBURN · NIH-10867373
This study is working on using computer technology to create better antibodies that can help treat serious illnesses like cancer and autoimmune diseases, making it easier for doctors to develop effective treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | AUBURN UNIVERSITY AT AUBURN (nih funded) |
| Locations | 1 site (Auburn, UNITED STATES) |
| Trial ID | NIH-10867373 on ClinicalTrials.gov |
What this research studies
This research focuses on developing advanced computational techniques to design therapeutic proteins, particularly antibodies, which play a crucial role in treating serious conditions like cancer and autoimmune diseases. By using computer software, the project aims to predict the properties of these proteins, making it easier to create more effective treatments. The methodology involves experimental verification of these computational designs to ensure they function as intended in real-world medical applications. This approach seeks to overcome current limitations in antibody production and application, ultimately enhancing patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from cancers or autoimmune diseases who may benefit from advanced therapeutic protein treatments.
Not a fit: Patients with conditions that do not involve the immune system or require therapeutic proteins may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and accessible therapeutic proteins for patients with serious illnesses.
How similar studies have performed: Other research has shown promise in using computational methods for protein design, indicating potential success for this novel approach.
Where this research is happening
Auburn, UNITED STATES
- AUBURN UNIVERSITY AT AUBURN — Auburn, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PANTAZES, ROBERT J — AUBURN UNIVERSITY AT AUBURN
- Study coordinator: PANTAZES, ROBERT J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diseases, Cancers